ARTICLE | Clinical News
Avandamet combination of rosiglitazone and metformin regulatory update
October 14, 2002 7:00 AM UTC
FDA granted marketing approval to GSK for its Avandamet to treat Type II diabetes. The use of rosiglitazone tablets with separate metformin tablets was approved by FDA in 1999. Rosiglitazone is market...